Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05155111 · ClinicalTrials.gov registry record · NA
Telemedicine to Reduce Disparities in the Identification and Treatment of Neonatal Encephalopathy
A NA study, sponsored by MaineHealth.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05155111 is a NA study that has completed, run by MaineHealth. The registered enrollment target is 23 participants.
The verdict
NCT05155111, a NA study, has completed, sponsored by MaineHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This is a clinical trial using telemedicine as an intervention twice in the first 6 hours of life to assess neonatal encephalopathy, one of the key factors involved in the decision to treat a neonate with therapeutic hypothermia (TH). The investigators aim to enroll up to 30 neonates, anticipating that there will be about 5 neonates, who do not demonstrate moderate to severe neonatal encephalopathy, and therefore do not meet criteria for treatment with TH. The investigators will prospectively follow the clinical course of all 30neonates through monitoring with electroencephalogram (EEG) for up to 24 hours after birth to determine if seizures are present and by MRI of the brain prior to hospital discharge to determine if there is evidence of brain injury. Neonates will be enrolled in the study for the duration of their hospital admission.
Interventions
- DIAGNOSTIC_TEST Telemedicine consult
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-12-22 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05155111
The ClinicalTrials.gov registry entry for NCT05155111 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MaineHealth, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telemedicine consult is the first listed.
NCT05155111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05155111 about?
NCT05155111 is a clinical study titled "Telemedicine to Reduce Disparities in the Identification and Treatment of Neonatal Encephalopathy". This is a clinical trial using telemedicine as an intervention twice in the first 6 hours of life to assess neonatal encephalopathy, one of the key factors involved in the decision to treat a neonate with therapeutic hypothermia (TH). The investigators aim to enroll up to 30 neonates, anticipating t...
What is the current status of trial NCT05155111?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2021-12-22. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05155111?
The interventions under investigation include: Telemedicine consult (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05155111?
This trial is sponsored by MaineHealth, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.